13 results
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Diagnosis - ... and EMG Findings ... immunologic assay - MuSK ... #Gravis #diagnosis ... #management #neurology
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
50 years in men Diagnosis ... : • Based on clinical ... - Improves clinical ... #Gravis #diagnosis ... #management #neurology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Clinical Features ... Diagnosis: • ... Albuminocytologic dissociation ... #Syndrome #diagnosis ... #neurology
Causes of Neuromuscular Weakness
 • Spinal Cord: Demyelinating Disease (MS), Epidural abscess, Infarction, Syringomyelia, Tetanus, Transverse
Demyelinating Disease (MS ... Poliomyelitis, Guillain-Barre ... Eaton Syndrome, Myasthenia ... #differential #diagnosis ... #neurology
Myasthenic Crisis Checklist - Myasthenia Gravis

Evaluation 
 - Chest X-ray and lung ultrasound (exclude other lung
X-ray and lung ultrasound ... Intubation only if clinically ... Pyridostigmine - New diagnosis ... (vital signs, clinical ... subjective dyspnea, etc
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
transplantation CLINICAL ... albuminocytologic dissociation ... and cauda equina TREATMENT ... specific therapy, the clinician ... #management #neurology
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
patients with clinically ... stimulation Clinical ... Multiple Sclerosis Treatment ... #management #neurology ... #treatment #MS
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
Toxicity - Summary Clinical ... myopathy, Guillain-Barré ... Lambert-Eaton myasthenic ... IU/I • SAMS clinical ... (SAMS-CI) • EMG
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Clinical Manifestations ... autoantibodies - TPO, TTG, etc ... Person Syndrome Treatment ... #Management #treatment ... #neurology
Giant cell arteritis (GCA)

Giant cell arteritis (GCA) definition: Most common systemic inflammatory vasculitis in older adults
with systemic, neurologic ... Diagnosis = clinical ... vision changes, etc ... of the steroid treatment ... Treatment of GCA